Ipsen: Early Engagement With Regulators Can Help Biomarker-Driven Drug R&D

 
• By Eliza Slawther

Regulators can help companies to determine which biomarker is right for their development program before starting clinical trials, boosting the chances of success, Ipsen’s head of early development says.

Ideas
• Source: Shutterstock

More from International

More from Geography